Full Breakdown
OpenEvidence Relocates to Florida, Secures $250 Million Funding and Announces Expansion
5/13/2026, 10:25:59 PM
Relocation and Expansion Overview
OpenEvidence, an artificial-intelligence firm that markets a chatbot described as “ChatGPT for doctors,” moved its headquarters from Massachusetts to Florida in 2025. The company announced an expansion of its diagnostic-support platform across the state, a move facilitated by a partnership with a national medical society.
Founding, Business Model, and Early Growth
Founded in 2022, OpenEvidence operates a specialized search engine that indexes peer-reviewed medical literature rather than the general internet. By limiting its corpus to vetted scientific studies, the platform distinguishes itself from broader AI chat services that draw from open-web content. The system is intended to assist physicians in generating evidence-based diagnoses and treatment recommendations.
Key Stakeholders
The firm’s capital base includes prominent venture investors Google Ventures, Sequoia Capital and Nvidia. Cumulative funding approaches $700 million. The national medical society collaborating on the Florida rollout is not named in the source material but is identified as a key partner in the expansion effort. The involvement of these investors reflects a blend of venture capital and strategic technology backing supporting OpenEvidence’s development.
Timeline of Major Milestones
- 2022 – OpenEvidence incorporated and launched its AI-driven search platform.
- 2025 – Headquarters relocated from Massachusetts to Florida.
- Early 2026 – Company closed a $250 million financing round.
- Q1 2026 – Valuation reached $12 billion, marking the largest funding round for a South-Florida startup in that quarter.
- 2026 – Expansion across Florida announced, supported by the national medical society.
Collectively, these milestones illustrate a rapid progression from a 2022 startup to a multi-billion-dollar enterprise within four years.
Funding and Valuation Details
OpenEvidence’s total capital raised totals approximately $700 million. The most recent $250 million infusion contributed to the firm’s $12 billion valuation. This financing round set a record for South-Florida startups in the first quarter of 2026, underscoring the scale of investor commitment to the company’s AI-driven health technology.
Official Statements and Responses
Company representatives indicated that the partnership with the national medical society will enable rapid deployment of the AI diagnostic tool within Florida’s healthcare network. The statement emphasized that the relocation aligns the firm with a supportive regulatory environment and a growing pool of medical professionals interested in AI-enhanced practice.
Conflicting Reports and Information Gaps
The source does not disclose the identity of the national medical society, nor does it provide specifics on the number of hospitals or clinics slated for the rollout. Details regarding the timeline for implementation and any regulatory approvals remain absent.
Implications for Florida’s Tech and Healthcare Landscape
The $250 million raise and $12 billion valuation position OpenEvidence as a flagship example of high-growth, AI-focused entrepreneurship in South Florida. The expansion may increase the availability of AI-assisted diagnostic support to clinicians throughout the state, potentially influencing clinical decision-making processes statewide while reinforcing Florida’s reputation as an emerging hub for health-tech innovation.
Upcoming Steps
OpenEvidence plans to extend its platform to additional Florida medical institutions throughout 2026, with the possibility of further fundraising to support scaling and product development.
